Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100403825> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3100403825 endingPage "44" @default.
- W3100403825 startingPage "33" @default.
- W3100403825 abstract "Long noncoding RNA (lncRNA) MAF BZIP transcription factor G antisense RNA 1 (MAFG‑AS1) has been demonstrated to serve an important role in the progression of various types of cancer, whereas its role in breast cancer has not been fully elucidated. The present study aimed to explore the potential role and underlying mechanism of MAFG‑AS1 in breast cancer. To achieve this, the expression of MAFG‑AS1, microRNA (miR)‑150‑5p and MYB was detected by reverse transcription‑quantitative PCR. The binding between miR‑150‑5p and MAFG‑AS1 or MYB was verified using a luciferase reporter assay. Cell proliferation was analyzed by MTS, apoptosis and cell cycle were detected by Annexin V/propidium iodide, and cell migration was analyzed by wound healing assay. The results demonstrated that the expression levels of MAFG‑AS1 were significantly upregulated in breast cancer tissues and cells compared with those in normal breast tissues and cells. High MAFG‑AS1 expression promoted the proliferation, migration and epithelial‑mesenchymal transition of breast cancer cells. By contrast, miR‑150‑5p expression was reduced in breast cancer tissues compared with that in healthy breast tissues, and low expression of miR‑150‑5p was associated with poor overall survival in patients with breast cancer. Bioinformatics and luciferase assay revealed that MAFG‑AS1 served as a sponge of miR‑150‑5p, and that miR‑150‑5p bound to MYB. The functional rescue assay results demonstrated that MAFG‑AS1 knockdown suppressed the proliferation and migration of breast cancer cells by regulating miR‑150‑5p, which in turn targeted MYB. In conclusion, the results of the present study demonstrated that MAFG‑AS1 functioned as a novel oncogenic lncRNA in the development of human breast cancer via regulating the miR‑150‑5p/MYB axis, which suggested that MAFG‑AS1 may be a novel biomarker for the diagnosis and prognosis of human breast cancer." @default.
- W3100403825 created "2020-11-23" @default.
- W3100403825 creator A5017839135 @default.
- W3100403825 creator A5028789471 @default.
- W3100403825 creator A5037210004 @default.
- W3100403825 creator A5061023690 @default.
- W3100403825 date "2020-11-20" @default.
- W3100403825 modified "2023-10-16" @default.
- W3100403825 title "Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells" @default.
- W3100403825 doi "https://doi.org/10.3892/ijo.2020.5150" @default.
- W3100403825 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7721084" @default.
- W3100403825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33367930" @default.
- W3100403825 hasPublicationYear "2020" @default.
- W3100403825 type Work @default.
- W3100403825 sameAs 3100403825 @default.
- W3100403825 citedByCount "19" @default.
- W3100403825 countsByYear W31004038252021 @default.
- W3100403825 countsByYear W31004038252022 @default.
- W3100403825 countsByYear W31004038252023 @default.
- W3100403825 crossrefType "journal-article" @default.
- W3100403825 hasAuthorship W3100403825A5017839135 @default.
- W3100403825 hasAuthorship W3100403825A5028789471 @default.
- W3100403825 hasAuthorship W3100403825A5037210004 @default.
- W3100403825 hasAuthorship W3100403825A5061023690 @default.
- W3100403825 hasBestOaLocation W31004038251 @default.
- W3100403825 hasConcept C104317684 @default.
- W3100403825 hasConcept C121608353 @default.
- W3100403825 hasConcept C145059251 @default.
- W3100403825 hasConcept C173396325 @default.
- W3100403825 hasConcept C190283241 @default.
- W3100403825 hasConcept C2775934118 @default.
- W3100403825 hasConcept C2781018059 @default.
- W3100403825 hasConcept C29537977 @default.
- W3100403825 hasConcept C31573885 @default.
- W3100403825 hasConcept C502942594 @default.
- W3100403825 hasConcept C530470458 @default.
- W3100403825 hasConcept C54355233 @default.
- W3100403825 hasConcept C62112901 @default.
- W3100403825 hasConcept C86803240 @default.
- W3100403825 hasConceptScore W3100403825C104317684 @default.
- W3100403825 hasConceptScore W3100403825C121608353 @default.
- W3100403825 hasConceptScore W3100403825C145059251 @default.
- W3100403825 hasConceptScore W3100403825C173396325 @default.
- W3100403825 hasConceptScore W3100403825C190283241 @default.
- W3100403825 hasConceptScore W3100403825C2775934118 @default.
- W3100403825 hasConceptScore W3100403825C2781018059 @default.
- W3100403825 hasConceptScore W3100403825C29537977 @default.
- W3100403825 hasConceptScore W3100403825C31573885 @default.
- W3100403825 hasConceptScore W3100403825C502942594 @default.
- W3100403825 hasConceptScore W3100403825C530470458 @default.
- W3100403825 hasConceptScore W3100403825C54355233 @default.
- W3100403825 hasConceptScore W3100403825C62112901 @default.
- W3100403825 hasConceptScore W3100403825C86803240 @default.
- W3100403825 hasIssue "1" @default.
- W3100403825 hasLocation W31004038251 @default.
- W3100403825 hasLocation W31004038252 @default.
- W3100403825 hasOpenAccess W3100403825 @default.
- W3100403825 hasPrimaryLocation W31004038251 @default.
- W3100403825 hasRelatedWork W1887054737 @default.
- W3100403825 hasRelatedWork W2024565062 @default.
- W3100403825 hasRelatedWork W2348417465 @default.
- W3100403825 hasRelatedWork W2529723636 @default.
- W3100403825 hasRelatedWork W2544787839 @default.
- W3100403825 hasRelatedWork W2562103693 @default.
- W3100403825 hasRelatedWork W2586385055 @default.
- W3100403825 hasRelatedWork W2699522849 @default.
- W3100403825 hasRelatedWork W2772993264 @default.
- W3100403825 hasRelatedWork W3045868324 @default.
- W3100403825 hasVolume "58" @default.
- W3100403825 isParatext "false" @default.
- W3100403825 isRetracted "false" @default.
- W3100403825 magId "3100403825" @default.
- W3100403825 workType "article" @default.